Industry Update – Second National Essential Diagnostics List – Draft

Draft of Second edition of “National Essential Diagnostics List” for public comment is released by Indian Council of Medical Research (ICMR), New Delhi

Public comments are invited on or before 15/1/2025 via email to mail id icmr.nedl2@gmail.com

Appreciating the urgent need to improve the availability of quality diagnostics at all levels of healthcare facilities in the country, Indian Council of Medical Research has drafted the second edition of National Essential Diagnostics List (NEDL).

The list has been drafted in consultations with all the relevant stakeholders for all levels of health care.

The comments/views on the draft may be forwarded via email at icmr.nedl2@gmail.com on or before 15/l/2025

Source: https://www.icmr.gov.in/icmrobject/uploads/Static/1735745135_draftsecondeditionnedl.pdf

Industry update : NABH GUIDEBOOK FOR CLIMATE ACTION AND SUSTAINABILITY IN HEALTHCARE

National Accreditation Board for Hospitals and Healthcare Providers (NABH) has been developing quality healthcare standards . NABH standards have always focused on creating an ecosystem for quality and safety of the services delivered in the healthcare organizations.

As a step towards addressing the biggest challenge of 21st century i.e. climate change and sustainability, NABH has developed a simple checklist to guide NABH accredited and certified healthcare organizations to achieve climate change adaption, resilience and sustainability.

This cohesive document includes essential of concept of sustainability in healthcare, guidance for implementation and strategic framework. To motivate healthcare organizations, industry best practices are also showcased in the document.

This document along with a self-assessment checklist is available for free download in NABH website http://www.nabh.co/

Source: http://www.nabh.co/

Industry Update – FICCI TANCARE 2025

15th Edition of FICCI TANCARE 2025 is scheduled on Saturday, 4th January 2025

Join healthcare leaders, innovators, and change-makers at FICCI TANCARE 2025 to explore cutting-edge developments and solutions in healthcare delivery.

Program Details are given below.

Theme: “Thinking for Tomorrow, Today: Embracing Changes in Healthcare”

Date: Saturday 4th January 2025

📍 Venue: Radisson Blu, Coimbatore

⏰ Time: 2 PM onwards

Program Objectives:

✅ Cutting-edge insights on healthcare innovations
✅ Networking with top industry leaders
✅ Panels by thought leaders
✅ Visionary discussions on healthcare excellence

Registration Link:
🔗 Register Now: https://lnkd.in/gju_9Yjr

Industry Associate Partners and Sponsors are welcome to connect to
sudharsan.ramu@ficci.com/ +91-9003052624

List of Eminent Speakers to the program are given below

Industry Update – Establishment of the Global Accreditation Cooperation

The establishment of the Global Accreditation Cooperation (GLOBAC) marks a significant shift in the global accreditation landscape, merging the International Accreditation Forum (IAF) and the International Laboratory Accreditation Cooperation (ILAC) into a single entity.

This transition, aimed to be operational by January 2026, follows extensive discussions and agreements among IAF and ILAC members in 2024.

Key Developments

Formation of GLOBAC:

In 2019, IAF and ILAC members decided to create GLOBAC, which will take over their existing roles. The formal incorporation process began in New Zealand in October 2024 after the approval of GLOBAC’s Constitution and General Rules.

Mutual Recognition:

GLOBAC aims to enhance international trade by ensuring mutual recognition of accredited services across borders, thereby removing technical barriers. Until GLOBAC becomes operational, IAF and ILAC will continue their normal operations with existing recognition arrangements remaining valid

Transition Plan

Before Transition Date:

Until the Transition Date, IAF and ILAC will maintain their operations, and existing guidance for regulators will remain applicable. The IAF Multilateral Recognition Arrangement (IAF MLA) and ILAC Mutual Recognition Arrangement (ILAC MRA) will continue to function until GLOBAC takes over

After Transition Date:

Following the Transition Date, GLOBAC will assume all responsibilities of IAF and ILAC. Regulations referencing IAF MLA or ILAC MRA will gradually be updated to reflect GLOBAC’s framework. It is anticipated that the use of IAF MLA and ILAC MRA Marks will cease three years post-transition

Recommendations for Regulators:

Regulators are encouraged to collaborate with IAF and ILAC members to prepare for necessary changes in their documentation as GLOBAC becomes operational. This proactive approach will facilitate a smoother transition to the new accreditation framework

For further inquiries regarding this transition, stakeholders can contact the GLOBAC Executive Committee through its Secretary : secretary@globac.org

Industry Update – World Health Innovation Forum 2024

Kalam Institute of Health Technology (KIHT), Vizag is organising the 2nd edition of World Health Innovation Forum 2024 at Vizag from December 12th to 14th 2024.

Key Highlights of the Program

a. To Explore Innovation in Healthcare.
b. To Create Public Private Partnerships Platform.
c. To Support Policy-Making in Healthcare
d. To Impact Global Health.

To explore the transformative learning, unparalleled networking opportunities and collaborative initiatives please click the link https://www.whif.kiht.in/registration/ and register for the program.

For additional details on the program, please contact:
Email : whif@kiht.in
Phone: +91 8341622261

Source: https://www.whif.kiht.in/

Industry Updates – MCA Notification Amendment Order – MSME

On July 15, 2024, the Ministry of Corporate Affairs issued an amendment to the Specified Companies (Furnishing of information about payment to micro and small enterprise suppliers) Order, 2019, namely Specified Companies (Furnishing of information about payment to micro and small enterprise suppliers) Amendment Order, 2024

Objectives

The amendment aims to improve transparency and accountability in corporate payments to micro and small enterprises, ensuring they receive timely payments essential for their operations and growth. This initiative helps protect the interests of smaller suppliers within the business landscape.

Summary of the Amendment

Title: Specified Companies (Furnishing of information about payment to micro and small enterprise suppliers) Amendment Order, 2024.

Effective Date: The amendment takes effect immediately upon publication in the Official Gazette.

Reporting Criteria: Only specified companies with payments pending to micro or small enterprises for more than 45 days from the acceptance date of goods or services must report this information using MSME Form-1.

Form Update: The existing MSME Form-1 has been replaced with a new form to better capture details about overdue payments.

Source: https://www.mca.gov.in/bin/ebook/dms/getdocument?doc=NDU5OTY2Mjky&docCategory=Notifications&type=open

Industry Update – MeDevIS (Medical Devices Information System) introduced by WHO

World Health Organization (WHO) has introduced an online platform called MeDevIS (Medical Devices Information System), the first global open access clearing house for information on medical devices. It is designed to support governments, regulators and users in their decision-making on selection, procurement and use of medical devices for diagnostics, testing and treatment of diseases and health conditions.

Here are the key insights from the news release about the MeDevIS platform from WHO :

Purpose and Scope: MeDevIS (Medical Devices Information System) is an online platform launched by WHO to provide global open access to information on medical devices. It aims to assist governments, regulators, and users in decision-making regarding the selection, procurement, and use of medical devices across various health conditions.

Coverage: The platform includes information on 2,301 types of medical devices used for a wide range of health issues, including reproductive health, noncommunicable diseases (e.g., cancer, cardiovascular diseases), infectious diseases (e.g., COVID-19), and more.

Complexity and Challenges: The increasing number and complexity of medical technologies make it challenging for healthcare practitioners and patients to navigate. MeDevIS aims to simplify access to reliable international information on medical devices, especially beneficial in resource-limited settings.

Functions and Features: Users can access detailed information about medical devices, including their types, suitable healthcare settings (e.g., community or specialized hospitals), scope of use, required infrastructure, and more. This replaces the need for separate searches across multiple publications with inconsistent naming conventions.

Nomenclature: MeDevIS incorporates two international naming systems for medical devices – the European Medical Device Nomenclature (EMDN) and the Global Medical Device Nomenclature (GMDN). These systems facilitate registration, procurement, regulatory approval, inventory management, and pricing of medical devices globally.

Impact and Benefits: The platform is expected to aid national policy-makers in developing procurement lists and contribute to universal health coverage goals. It can also support health insurance and reimbursement policies, benefiting patients globally.

Future Developments: WHO plans to continually improve MeDevIS by engaging stakeholders and expanding its coverage with additional medical technologies, including those needed in pandemic and emergency settings.

Overall, MeDevIS represents a significant initiative by WHO to enhance access to crucial medical technologies and devices worldwide, streamlining information dissemination and improving healthcare delivery.

Source:https://www.who.int/news/item/08-07-2024-medevis-platform-announced-to-boost-access-to-medical-technologies-and-devices

Industry Update

CDSCO (Central Drugs Standard Control Organisation) has issued a Circular on 22nd May 2024 relating to the Blood Centre Situated in Hospital or Hospital Campus.

It is clarified that the Blood Centre run by the Hospital means the Blood centre situated in the Hospital premises. Application for grant / renewal of license for blood centre by a Hospital will be considered accordingly.

Further as per Provision under rules 122-G of the Drug Rules, 1945, applications for grant or renewal of license will be continued to be accepted by the State Drugs Department and the CDSCO for operation of Blood Centre or processing of Human Blood components run by Government, Indian Red Cross Society, Hospital, Charitable Trust or Voluntary Organisation.

Source: https://cdsco.gov.in/opencms/opencms/en/Notifications/Circulars/

GUIDELINES FOR INTER-DEPARTMENTAL REFERRALS(WITHIN HOSPITAL)2024

Inter Departmental referral process is a crucial component of high quality comprehensive patient care in any Medical Institution. However there are inconsistencies and lack of accountability in the referral process. To address the various issues prevailing in the inter departmental referral process, Director General of Health Services, Ministry of Health & Family Welfare has issued Guidelines for Inter-Departmental Referral within a hospital.

These guidelines provide a framework to various hospitals to improve patient care services, facilitate better communication and cooperation between departments, enhance working relationships and help develop accountability in a hospital.

Hospitals should develop their internal Standard Operating Procedures using the guidelines issued by the Directorate.

DO’S AND DON’TS FOR INTER-DEPARTMENTAL REFERRALS AT HOSPITALS

DO’s

a. To Initiate referrals promptly
b. To document referrals accurately
c. Effective Communication
d. Acknowledge and update referrals
e. Collaborate for Continuity of Care
f. Follow up on referrals
g. Respect patient confidentiality
h. Seek feedback for improvement
i. Adhere to hospital policies and best practices
j. Prioritise patient centered care

DONT’s

a.Don’t delay referrals unnecessarily
b.Don’t omit essential clinical information or documentation
c.Don’t assume that all referrals are routine or non-urgent;
d.Don’t overlook communication
e.Don’t rely solely on verbal communication
f. Don’t hesitate to escalate urgent referrals
g.Don’t breach patient confidentiality
h.Don’t ignore feedback
i. Don’t overlook importance of ongoing education and training
j. Don’t lose sight of patient’s overall well-being

Source: Ministry of Health & Family Welfare Directorate Guideline document

DRAFT AMENDMENTS TO THE CCI REGULATIONS, 2009

CCI (Competition Commission of India) is amending its Regulations and the notification was released on June 6th 2024. Public Consultation is open and comments are invited from the public.

Consultation on draft ‘The Competition Commission of India (General) Regulations, 2009’ Back ground Note for the proposed amendment and proposed draft amendments are posted in the CCI’s portal. Sharing the links below for the same.


Background Note https://cci.gov.in/images/stakeholderstopicsconsultations/en/background-note1717612208.pdf

Draft amendmentshttps://cci.gov.in/images/stakeholderstopicsconsultations/en/draft-amendments-to-the-cci-general-regulations-20091717612278.pdf

The stakeholders can submit written comments on the draft amendments to the Competition Commission of India (General) Regulations, 2009, within 30 (thirty) days from 06.06.2024 to 08.07.2024.

The stakeholders can submit their comments at the link shared below: https://cci.gov.in/stakeholders-consultations/30

source : https://cci.gov.in/stakeholders-topics-consultations